Jacob Vincent Micallef

Title: Jacob Vincent Micallef: Innovator in Cancer Detection Technologies

Introduction

Jacob Vincent Micallef is a notable inventor based in Belgium. He has made significant contributions to the field of cancer detection through his innovative research and inventions. His work focuses on the use of histone binding agents and nucleosome-transcription factor complexes for the detection and diagnosis of cancer.

Latest Patents

Jacob has developed several groundbreaking patents, including:

1. **Method for the Enrichment of Circulating Tumor DNA** - This invention relates to the use of histone binding agents for detecting, isolating, and purifying cell-free nucleosomes of tumor origin or circulating tumor DNA from biological samples. It also includes methods and kits utilizing these histone binding agents.

2. **Use of Nucleosome-Transcription Factor Complexes for Cancer Detection** - This invention focuses on the use of tissue-specific transcription factor-nucleosome adducts or transcription cofactor-nucleosome adducts as biomarkers in biological fluids for cancer detection or diagnosis. It further relates to identifying the site of cancer development in a subject using these adducts.

Career Highlights

Jacob is currently employed at Belgian Volition Srl, where he continues to advance his research in cancer detection technologies. His innovative approaches have the potential to significantly improve cancer diagnostics and patient outcomes.

Collaborations

Jacob collaborates with Marielle Herzog, contributing to the development of new methodologies in their field.

Conclusion

Jacob Vincent Micallef is a pioneering inventor whose work in cancer detection technologies is making a substantial impact. His innovative patents and ongoing research hold promise for the future of cancer diagnostics.